ACT BORTEZOMIB DIN 02438399
Status: Marketed
Holder: TEVA CANADA LIMITED
Available to quote
Health Canada record
| Active ingredient(s) | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Subcutaneous; Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01XG01 BORTEZOMIB |
| Original market date | 17-Nov-2015 |
| Current status date | 30-Dec-2020 |
| Source | Health Canada DPD |
Establishment licence of the holder
Teva Canada Limited — licence 101810, currently licensed, last inspection rating C (2025-03-04).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02456176 | BORTEZOMIB | APOTEX INC | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Marketed |
| 02423405 | BORTEZOMIB FOR INJECTION | TEVA CANADA LIMITED | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Marketed |
| 02452456 | BORTEZOMIB FOR INJECTION | DR REDDY'S LABORATORIES LTD | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Marketed |
| 02547287 | BORTEZOMIB FOR INJECTION | HIKMA CANADA LIMITED | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Approved |
| 02541777 | BORTEZOMIB FOR INJECTION | GENERIC MEDICAL PARTNERS INC | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Approved |
| 02467003 | BORTEZOMIB FOR INJECTION | PFIZER CANADA ULC | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 2.5 MG | Marketed |
| 02467011 | BORTEZOMIB FOR INJECTION | PFIZER CANADA ULC | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Approved |
| 02480255 | BORTEZOMIB FOR INJECTION | PFIZER CANADA ULC | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 1 MG | Approved |
| 02480263 | BORTEZOMIB FOR INJECTION | PFIZER CANADA ULC | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3 MG | Approved |
| 02485257 | BORTEZOMIB FOR INJECTION | JUNO PHARMACEUTICALS CORP. | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Marketed |
| 02493306 | BORTEZOMIB FOR INJECTION | MARCAN PHARMACEUTICALS INC | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Marketed |
| 02497433 | BORTEZOMIB FOR INJECTION | AURO PHARMA INC | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Approved |
| 02536773 | BORTEZOMIB FOR INJECTION | EUGIA PHARMA INC. | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Approved |
| 02550075 | BORTEZOMIB INJECTION | DR REDDY'S LABORATORIES LTD | Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 2.5 MG | Marketed |
| 02466708 | PMS-BORTEZOMIB | PHARMASCIENCE INC | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Marketed |
| 02521814 | TARO-BORTEZOMIB | TARO PHARMACEUTICALS INC | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 1 MG | Approved |
| 02499061 | TARO-BORTEZOMIB | TARO PHARMACEUTICALS INC | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Marketed |
| 02511932 | TARO-BORTEZOMIB | TARO PHARMACEUTICALS INC | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 2.5 MG | Marketed |
| 02262452 | VELCADE | JANSSEN INC | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Marketed |
| 02494922 | BORTEZOMIB FOR INJECTION | JUNO PHARMACEUTICALS CORP. | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 1 MG | Cancelled Pre Market |
| 02453487 | BORTEZOMIB FOR INJECTION | SANDOZ CANADA INCORPORATED | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Cancelled Pre Market |
| 02494930 | BORTEZOMIB FOR INJECTION | JUNO PHARMACEUTICALS CORP. | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 2.5 MG | Cancelled Post Market |
| 02503352 | BORTEZOMIB FOR INJECTION SDZ | SANDOZ CANADA INCORPORATED | Powder For Solution | BORTEZOMIB (BORTEZOMIB MANNITOL BORONIC ESTER) 3.5 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 24902 | 2020-12-30 | Abbreviated New Drug Submission (ANDS) | MERGER - BUYOUT. UPDATE INNER AND OUTER LABELS AND PACKAGE INSERT TO COMPLY WITH PLL |
| 16930 | 2015-05-25 | Abbreviated New Drug Submission (ANDS) |